Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300971 | PMC |
| http://dx.doi.org/10.1016/j.xjtc.2021.01.039 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Transcatheter Mitral Valve-in-Valve Replacement as a First-Line Treatment for Bioprosthetic Valve Failure.
Circ Cardiovasc Interv
August 2024
Department of Cardiovascular Medicine, Cleveland Clinic, OH.
Transcatheter or Surgical Replacement for Failed Bioprosthetic Aortic Valves.
JAMA Cardiol
July 2024
Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
Importance: The use of valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) has been rapidly expanding as an alternative treatment to redo surgical aortic valve replacement (SAVR) for failed bioprosthetic valves despite limited long-term data.
Objective: To assess mortality and morbidity in patients undergoing intervention for failed bioprosthetic SAVR.
Design, Setting, And Participants: This was a retrospective population-based cohort analysis conducted between January 1, 2015, and December 31, 2020, with a median (IQR) follow-up time of 2.
The real-life treatments and surgeons' opinions on aortic valve diseases in non-elderly patients.
Eur J Cardiothorac Surg
November 2023
Department of Cardiac Surgery, University of Michigan, Ann Arbor, MI, USA.
Bioprosthetic Valve Remodeling in Nonfracturable Surgical Valves.
JACC Cardiovasc Interv
September 2023
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!